These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1659844)

  • 21. Neuroendocrine tumors of the lung. Pathology and molecular biology.
    Vuitch F; Sekido Y; Fong K; Mackay B; Minna JD; Gazdar AF
    Chest Surg Clin N Am; 1997 Feb; 7(1):21-47. PubMed ID: 9001754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic strategies of tumor suppression.
    Sager R
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S40-3. PubMed ID: 2174661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biology of lung cancer.
    Carney DN
    Bull Cancer; 1987; 74(5):495-500. PubMed ID: 2825849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
    Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between fluorescence in situ hybridization and classical cytogenetics in human tumors.
    Virmani AK; Tonk VS; Gazdar AF
    Anticancer Res; 1998; 18(3A):1351-6. PubMed ID: 9673339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biology of small-cell bronchogenic carcinoma: recent advances].
    Levy R; Andrieu JM; Even P
    Bull Cancer; 1992; 79(1):25-46. PubMed ID: 1325850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunohistochemistry of biomolecular markers of lung cancer].
    Kogan EA; Zhak G; Kaĭzer U; Shilli M; Shurman M; Sherer A; Khavemann K
    Arkh Patol; 1997; 59(6):23-30. PubMed ID: 9483214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.
    Gazdar AF; Mulshine JL; Kramer BS
    Immunol Ser; 1990; 53():453-68. PubMed ID: 1966068
    [No Abstract]   [Full Text] [Related]  

  • 29. Biological prognostic factors in non-small cell lung cancer.
    Scagliotti GV; Masiero P; Pozzi E
    Lung Cancer; 1995 Apr; 12 Suppl 1():S13-25. PubMed ID: 7551921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle alterations and lung cancer.
    Vincenzi B; Schiavon G; Silletta M; Santini D; Perrone G; Di Marino M; Angeletti S; Baldi A; Tonini G
    Histol Histopathol; 2006 Apr; 21(4):423-35. PubMed ID: 16437388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular biology of lung cancer.
    Kaye FJ
    Lung Cancer; 2001 Dec; 34 Suppl 2():S35-41. PubMed ID: 11720739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity.
    Daly MC; Xiang RH; Buchhagen D; Hensel CH; Garcia DK; Killary AM; Minna JD; Naylor SL
    Oncogene; 1993 Jul; 8(7):1721-9. PubMed ID: 8390035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer.
    Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J
    Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosomal imbalances in human lung cancer.
    Balsara BR; Testa JR
    Oncogene; 2002 Oct; 21(45):6877-83. PubMed ID: 12362270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung.
    Hosoe S; Ueno K; Shigedo Y; Tachibana I; Osaki T; Kumagai T; Tanio Y; Kawase I; Nakamura Y; Kishimoto T
    Cancer Res; 1994 Apr; 54(7):1787-90. PubMed ID: 7907944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
    Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
    Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oncogenes, differentiation markers and morphological criteria as prognostic parameters in non-small-cell bronchial carcinoma].
    Thomas M; Junker K
    Dtsch Med Wochenschr; 1997 Oct; 122(43):1327-31. PubMed ID: 9410698
    [No Abstract]   [Full Text] [Related]  

  • 38. The FHIT gene 3p14.2 is abnormal in lung cancer.
    Sozzi G; Veronese ML; Negrini M; Baffa R; Cotticelli MG; Inoue H; Tornielli S; Pilotti S; De Gregorio L; Pastorino U; Pierotti MA; Ohta M; Huebner K; Croce CM
    Cell; 1996 Apr; 85(1):17-26. PubMed ID: 8620533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent progress in the biology of small cell bronchial carcinoma].
    Thomas F; Arriagada R; Le Chevalier T; Poupon MF
    Rev Mal Respir; 1988; 5(5):451-61. PubMed ID: 2847257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung.
    Brauch H; Johnson B; Hovis J; Yano T; Gazdar A; Pettengill OS; Graziano S; Sorenson GD; Poiesz BJ; Minna J
    N Engl J Med; 1987 Oct; 317(18):1109-13. PubMed ID: 2821398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.